Cart
sales@molnova.com
Piperidine-MO-1
CAS No. 871351-61-0
Piperidine-MO-1( —— )
Catalog No. M26380 CAS No. 871351-61-0
Piperidine-MO-1 is a dopamine receptor modulator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 153 | In Stock |
|
| 10MG | 225 | In Stock |
|
| 25MG | 337 | In Stock |
|
| 50MG | 465 | In Stock |
|
| 100MG | 625 | In Stock |
|
| 200MG | 828 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePiperidine-MO-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPiperidine-MO-1 is a dopamine receptor modulator.
-
DescriptionPiperidine-MO-1 is a dopamine receptor modulator.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSIRT1| SIRT2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number871351-61-0
-
Formula Weight321.84
-
Molecular FormulaC14H21ClFNO2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.CCN1CCC(CC1)c1cccc(c1F)S(C)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Park JB. Finding Potent Sirt Inhibitor in Coffee: Isolation, Confirmation and Synthesis of Javamide-II (N-Caffeoyltryptophan) as Sirt1/2 Inhibitor. PLoS One. 2016 Mar 17;11(3):e0150392.
molnova catalog
related products
-
(Ser8)-GLP-1 (7-36) ...
(Ser8)-GLP-1 (7-36) amide, human is a glucagon-like peptide 1 amide derived from glucagonogen, a cleavage product of the GLP-1 (1-36) amide peptide. (Ser8)-GLP-1 (7-36) amide, human is an entero-insulinotropic hormone that causes glucose-dependent release of insulin from pancreatic β-cells and affects gastrointestinal motility and secretion.
-
10-(Phosphonooxy)dec...
10-(Phosphonooxy)decyl methacrylate (10-methacryloyloxydecyl dihydrogen phosphate) is an adhesive that can modify the surface of dentin and improve the stability of dentin bonding.
-
DL-Carnitine
Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.
